SMTL ID : 6ykg.1

Structure-based exploration of selectivity for ATM inhibitors in Huntingtons disease

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 3.12 Å

Oligo State

monomer

Ligands

1 x OZ8: 4-morpholin-4-yl-6-[(2~{R})-2-(phenylmethyl)pyrrolidin-1-yl]-1~{H}-pyridin-2-one(Non-covalent)

OZ8.1: 17 residues within 4Å: Chain A: A.368, S.370, P.374, L.390, K.392, Y.426, L.438, Q.439, W.440, I.441, S.444, V.445, P.446, L.507, F.515, I.517, D.518 11 PLIP interactions: 11 interactions with chain A Hydrophobic interactions: A:A.368, A:L.438, A:W.440, A:W.440, A:P.446, A:L.507, A:I.517 Hydrogen bonds: A:K.392, A:I.441, A:S.444, A:D.518

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Van de Poel, A. et al., Structure-Based Exploration of Selectivity for ATM Inhibitors in Huntington's Disease. J.Med.Chem. (2021)

Release Date

2021-04-14

Peptides

Phosphatidylinositol 3-kinase catalytic subunit type 3: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
AAA

Phosphatidylinositol 3-kinase catalytic subunit type 3